PTGDR2 and cancer: The present paper aims to continue to summarize current indole-based potential GPR44 analogues and cyclopentenylindole-based potential GPR44 analogues containing a fluorine group and evaluate their potential as treatment targets, to provide a more complete map of current GPR44 analogues containing a fluorine group as options for cancer-related inflammation PET tracer development.